Chantévy Pou

926 total citations
16 papers, 758 citations indexed

About

Chantévy Pou is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cancer Research. According to data from OpenAlex, Chantévy Pou has authored 16 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 4 papers in Cancer Research. Recurrent topics in Chantévy Pou's work include Receptor Mechanisms and Signaling (6 papers), Neuropeptides and Animal Physiology (6 papers) and Cancer Genomics and Diagnostics (4 papers). Chantévy Pou is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Neuropeptides and Animal Physiology (6 papers) and Cancer Genomics and Diagnostics (4 papers). Chantévy Pou collaborates with scholars based in Canada, United Kingdom and United States. Chantévy Pou's co-authors include Kemal Payza, Claude Godbout, Ralf Schmidt, W. A. Brown, Tomas Hökfelt, Dajan O’Donnell, Paola Lembo, Manon Pelletier, Philippe Walker and Pablo R. Brumovsky and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Chantévy Pou

16 papers receiving 739 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chantévy Pou Canada 11 445 443 230 138 112 16 758
Nanda Tilakaratne Australia 13 764 1.7× 707 1.6× 112 0.5× 53 0.4× 76 0.7× 18 991
Yossan‐Var Tan France 18 502 1.1× 408 0.9× 89 0.4× 25 0.2× 57 0.5× 26 794
M. Lis Canada 18 702 1.6× 658 1.5× 287 1.2× 83 0.6× 185 1.7× 33 1.0k
S. Zakarian United Kingdom 11 628 1.4× 465 1.0× 229 1.0× 47 0.3× 162 1.4× 15 852
Atsuro Oishi France 10 155 0.3× 296 0.7× 251 1.1× 22 0.2× 77 0.7× 19 576
Steven C. Prinster United States 6 281 0.6× 388 0.9× 83 0.4× 70 0.5× 88 0.8× 7 528
László Szidonya Hungary 12 216 0.5× 342 0.8× 60 0.3× 40 0.3× 52 0.5× 24 633
Jean Danao United States 9 98 0.2× 163 0.4× 73 0.3× 42 0.3× 103 0.9× 9 483
Jean‐Claude Beaujouan France 21 1.0k 2.3× 880 2.0× 49 0.2× 17 0.1× 196 1.8× 34 1.2k
Edward Kaftan United States 15 479 1.1× 790 1.8× 38 0.2× 23 0.2× 175 1.6× 24 1.2k

Countries citing papers authored by Chantévy Pou

Since Specialization
Citations

This map shows the geographic impact of Chantévy Pou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chantévy Pou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chantévy Pou more than expected).

Fields of papers citing papers by Chantévy Pou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chantévy Pou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chantévy Pou. The network helps show where Chantévy Pou may publish in the future.

Co-authorship network of co-authors of Chantévy Pou

This figure shows the co-authorship network connecting the top 25 collaborators of Chantévy Pou. A scholar is included among the top collaborators of Chantévy Pou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chantévy Pou. Chantévy Pou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Baker, Matthew J., et al.. (2021). Optimisation of an Electrochemical DNA Sensor for Measuring KRAS G12D and G13D Point Mutations in Different Tumour Types. Biosensors. 11(2). 42–42. 17 indexed citations
2.
Evans, T.R. Jeffry, Martin Eatock, Liz-Anne Lewsley, et al.. (2020). A phase I study of olaparib in combination with capecitabine-based chemoradiation (CRT) in patients (pts) with locally advanced pancreatic cancer (LAPC).. Journal of Clinical Oncology. 38(4_suppl). 709–709. 4 indexed citations
3.
Baker, Matthew J., et al.. (2020). Electrochemical DNA Detection Methods to Measure Circulating Tumour DNA for Enhanced Diagnosis and Monitoring of Cancer. MDPI (MDPI AG). 15–15. 1 indexed citations
4.
Pou, Chantévy, Ewen O. Blair, Christopher Rinaldi, et al.. (2020). Developing a Low-Cost, Simple-to-Use Electrochemical Sensor for the Detection of Circulating Tumour DNA in Human Fluids. Biosensors. 10(11). 156–156. 17 indexed citations
5.
Glasspool, Rosalind, Sarah P. Blagden, Michelle Lockley, et al.. (2017). A phase I trial of the oral hedgehog inhibitor taladegib (LY2940680) in combination with weekly paclitaxel in patients with advanced, solid tumours.. Journal of Clinical Oncology. 35(15_suppl). 2594–2594. 3 indexed citations
6.
Marsango, Sara, et al.. (2015). Analysis of Human Dopamine D3 Receptor Quaternary Structure. Journal of Biological Chemistry. 290(24). 15146–15162. 20 indexed citations
7.
Pou, Chantévy, Clotilde Mannoury la Cour, Leigh A. Stoddart, Mark J. Millan, & Graeme Milligan. (2012). Functional Homomers and Heteromers of Dopamine D2L and D3 Receptors Co-exist at the Cell Surface. Journal of Biological Chemistry. 287(12). 8864–8878. 37 indexed citations
8.
Pou, Chantévy, et al.. (2008). Neurotrophic Actions of PACAP-38 and LIF on Human Neuroblastoma SH-SY5Y Cells. Journal of Molecular Neuroscience. 36(1-3). 45–56. 13 indexed citations
9.
Digan, Mary Ellen, Chantévy Pou, Honglin Niu, & Ji-Hu Zhang. (2005). Evaluation of Division-Arrested Cells for Cell-Based High-Throughput Screening and Profiling. SLAS DISCOVERY. 10(6). 615–623. 19 indexed citations
10.
Liu, Hongxiang, Pablo R. Brumovsky, Ralf Schmidt, et al.. (2001). Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord: Selective actions via GalR1 and GalR2 receptors. Proceedings of the National Academy of Sciences. 98(17). 9960–9964. 190 indexed citations
11.
Ma, Xiaosong, Yong‐Guang Tong, Ralf Schmidt, et al.. (2001). Effects of galanin receptor agonists on locus coeruleus neurons. Brain Research. 919(1). 169–174. 70 indexed citations
12.
Lembo, Paola, Eric Grazzini, Douglas A. Hubatsch, et al.. (1999). The receptor for the orexigenic peptide melanin-concentrating hormone is a G-protein-coupled receptor. Nature Cell Biology. 1(5). 267–271. 212 indexed citations
13.
Schmidt, Ralf, Shi Yi Yue, Chantévy Pou, et al.. (1999). The Glycine1Residue in Cyclic Lactam Analogues of Galanin(1−16)-NH2Is Important for Stabilizing an N-Terminal Helix. Biochemistry. 38(46). 15295–15304. 30 indexed citations
14.
O’Donnell, Dajan, Huy Khang Vu, Kemal Payza, et al.. (1998). Cloning and Characterization of a cDNA Encoding a Novel Subtype of Rat Thyrotropin-releasing Hormone Receptor. Journal of Biological Chemistry. 273(48). 32281–32287. 111 indexed citations
15.
Pou, Chantévy, Emmanuel K. Nénonéné, Tomás A. Reader, & A. Fargin. (1997). The human 5-HT1A receptor: comparison of its binding properties in transfected cells and cortical tissue. General Pharmacology The Vascular System. 29(5). 737–747. 7 indexed citations
16.
Fenrick, Randy, et al.. (1996). The human 5-hydroxytryptamine 1A receptor differentially modulates phospholipase c and adenylyl cyclase activities. General Pharmacology The Vascular System. 27(2). 263–268. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nanda Tilakaratne Breakdown of academic impact, for papers by Yossan‐Var Tan Breakdown of academic impact, for papers by M. Lis Breakdown of academic impact, for papers by S. Zakarian Breakdown of academic impact, for papers by Atsuro Oishi Breakdown of academic impact, for papers by Steven C. Prinster Breakdown of academic impact, for papers by László Szidonya Breakdown of academic impact, for papers by Jean Danao Breakdown of academic impact, for papers by Jean‐Claude Beaujouan Breakdown of academic impact, for papers by Edward Kaftan
Rankless by CCL
2026